Atom Investors’s Arvinas ARVN Stock Holding History

Atom Investors’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,877	Closed	-$235K	–	596
2025 Q2	$235K	Buy	+31,877	New	+$235K	0.02%	482
2021 Q2	–	Sell	-34,938	Closed	-$2.31M	–	246
2021 Q1	$2.31M	Sell	34,938 -37,063	-51%	-$2.84M	0.39%	58
2020 Q4	$6.12M	Buy	72,001 +62,743	+678%	+$2.16M	0.62%	45
2020 Q3	$219K	Buy	+9,258	New	+$268K	0.02%	339

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Atom Investors's ARVN Position: Q3 2025 in Review

Atom Investors sold out of Arvinas (ARVN) in Q3 2025, closing a stake of 31,877 shares — an estimated $235K sold.

Atom Investors first reported a position in ARVN in Q3 2020 and held it in 4 quarters. The position peaked at $6.12M in Q4 2020. 211 funds tracked by Wall St. Rank hold ARVN as of Q3 2025.

Atom Investors reported no remaining Arvinas position as of Q3 2025 after selling out during the quarter.
Atom Investors sold 31,877 Arvinas shares in Q3 2025, an estimated $235K.
Atom Investors first reported a position in Arvinas in Q3 2020 and held it in 4 quarters.
Atom Investors's Arvinas position peaked at $6.12M in Q4 2020.
211 funds tracked by Wall St. Rank held Arvinas as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.